Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 12.43 -0.31 (2.43%)
Previous Close $12.74    52 Week High $30.40 
Open $12.50    52 Week Low $11.86 
Day High $12.82    P/E N/A 
Day Low $12.19    EPS $0.00 
Volume 3,446,458